An AHP research on the sustainable innovation policy system of biomedicine in ChinaHAN Peng, WU Zhi-ang513-522
Considerations on the analytical similarity study between monoclonal antibody biosimilars and reference drugsLI Si-peng, ZHANG Zhong-li, XU Sheng-chang, ZHANG Lei523-531
Overall consideration and comparative analysis of modified new drug in China and 505( b) (2) pathway drug application in the U. S.GUO Can-hui, CAO Yu-ping, CHEN Cheng, BAI Yi-jun, YUAN Jing-chan532-535
The physicochemical properties of crude polysaccharides and their fractions from roots of Ranunculus ternatus and their protection effects on drug-induced liver cell injuryYAO Hui, LUO Fu-yao, MA Hao, GU Jia-nan, GAO Yue-qiu, SHAN Jun-jie544-554
Research progress on chemical constituents and pharmacological effects of medicinal plants in genus RheumZHANG Kai-xian, YAO Qiu-yang, WU Fa-ming, LIU Sha555-566
Research progress in inhaled powder aerosols of solid lipid nanoparticlesWANG Min, YANG Zhong-lan, ZHOU Li-li, NING Shuang-cheng, ZHOU Zhi-gang, WANG Lan, MO Mei-xia, XIA Xin-hua567-572
Research progress on follicle stimulating hormone and its measurement methodsZHANG Yuan, WU Yan-lin, ZHANG Ming-lu, YANG Ze-an, GAO Hua573-578
Investigation and analysis of the current situation of the writing of investigator's brochures for drug clinical trialsCAO Ye, ZHUO Jun-cheng, JIANG Wen-yue, CHEN Wen-na579-585
Several thoughts on conduction of clinical trials under institution registration systemZHANG Ying-ying, LI Jing, LI Ming, DU Ya-wei, ZHU Yu-mei, WU Sheng-xian586-589